相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis
Stephan Philipp et al.
CELL COMMUNICATION AND SIGNALING (2015)
Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics
Gi-Bang Koo et al.
CELL RESEARCH (2015)
Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy
Xiaoyun Dai et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2015)
Suppression of RIP3-dependent Necroptosis by Human Cytomegalovirus
Shinya Omoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Apoptosis, autophagy, necroptosis, and cancer metastasis
Zhenyi Su et al.
MOLECULAR CANCER (2015)
Necroptosis and its role in inflammation
Manolis Pasparakis et al.
NATURE (2015)
Ppm1b negatively regulates necroptosis through dephosphorylating Rip3
Wanze Chen et al.
NATURE CELL BIOLOGY (2015)
Live to die another way: modes of programmed cell death and the signals emanating from dying cells
Yaron Fuchs et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
A cytosolic heat shock protein 90 and cochaperone CDC37 complex is required for RIP3 activation during necroptosis
Dianrong Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8+ T cells
Nader Yatim et al.
SCIENCE (2015)
Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death
K. Moriwaki et al.
CELL DEATH & DISEASE (2015)
Neoalbaconol induces cell death through necroptosis by regulating RIPK-dependent autocrine TNFα and ROS production
Xinfang Yu et al.
ONCOTARGET (2015)
RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1α release, and efficient paracrine dendritic cell activation
Susanne V. Schmidt et al.
ONCOTARGET (2015)
PolyI:C-Induced, TLR3/RIP3-Dependent Necroptosis Backs Up Immune Effector-Mediated Tumor Elimination In Vivo
Ryo Takemura et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Regulation of tumour necrosis factor signalling: live or let die
Dirk Brenner et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Necroptosis Is Active in Children With Inflammatory Bowel Disease and Contributes to Heighten Intestinal Inflammation
Maria Pierdomenico et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
TRAIL-induced programmed necrosis as a novel approach to eliminate tumor cells
Susann Voigt et al.
BMC CANCER (2014)
Polyphenon E, a standardized green tea extract, induces endoplasmic reticulum stress, leading to death of immortalized PNT1a cells by anoikis and tumorigenic PC3 by necroptosis
Federica Rizzi et al.
CARCINOGENESIS (2014)
Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments
H. Inoue et al.
CELL DEATH AND DIFFERENTIATION (2014)
The protein disulfide isomerases PDIA4 and PDIA6 mediate resistance to cisplatin-induced cell death in lung adenocarcinoma
G. Tufo et al.
CELL DEATH AND DIFFERENTIATION (2014)
Getting TRAIL back on track for cancer therapy
J. Lemke et al.
CELL DEATH AND DIFFERENTIATION (2014)
Nuclear Death Receptor TRAIL-R2 Inhibits Maturation of Let-7 and Promotes Proliferation of Pancreatic and Other Tumor Cells
Verena Haselmann et al.
GASTROENTEROLOGY (2014)
Toll-like Receptor-mediated Down-regulation of the Deubiquitinase Cylindromatosis ( CYLD) Protects Macrophages from Necroptosis in Wild-derived Mice
Stephen A. Schworer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Selenium induces a multi- targeted cell death process in addition to ROS formation
Marita Wallenberg et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
The AMPK Inhibitor Compound C Is a Potent AMPK-Independent Antiglioma Agent
Xiaona Liu et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Mixed Lineage Kinase Domain-like Protein MLKL Causes Necrotic Membrane Disruption upon Phosphorylation by RIP3
Huayi Wang et al.
MOLECULAR CELL (2014)
Necroptosis
Andreas Linkermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A JNK-mediated autophagy pathway that triggers c-IAP degradation and necroptosis for anticancer chemotherapy
W. He et al.
ONCOGENE (2014)
PPM1A is a RelA phosphatase with tumor suppressor-like activity
X. Lu et al.
ONCOGENE (2014)
Receptor Interactive Protein Kinase 3 Promotes Cisplatin-Triggered Necrosis in Apoptosis-Resistant Esophageal Squamous Cell Carcinoma Cells
Yang Xu et al.
PLOS ONE (2014)
GSK3A Is Redundant with GSK3B in Modulating Drug Resistance and Chemotherapy-Induced Necroptosis
Emanuela Grassilli et al.
PLOS ONE (2014)
Therapeutic exploitation of necroptosis for cancer therapy
Simone Fulda
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)
Targeting death receptors for TRAIL by agents designed by Mother Nature
Sandeo Prasad et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Triggering necroptosis in cisplatin and IAP antagonist-resistant ovarian carcinoma
K. E. McCabe et al.
CELL DEATH & DISEASE (2014)
Induction of apoptosis and necroptosis by 24(S)-hydroxycholesterol is dependent on activity of acyl-CoA: cholesterol acyltransferase 1
K. Yamanaka et al.
CELL DEATH & DISEASE (2014)
RIP3 is downregulated in human myeloid leukemia cells and modulates apoptosis and caspase-mediated p65/RelA cleavage
A-L Nugues et al.
CELL DEATH & DISEASE (2014)
Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1-and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells
M. A. Babcook et al.
CELL DEATH & DISEASE (2014)
Regulated cell death and inflammation: an auto-amplification loop causes organ failure
Andreas Linkermann et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia
Karen A. Urtishak et al.
BLOOD (2013)
The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis
Zeze Fu et al.
BMC CANCER (2013)
Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma
Lauren E. Colbert et al.
CANCER (2013)
Obatoclax (GX15-070) triggers necroptosis by promoting the assembly of the necrosome on autophagosomal membranes
F. Basit et al.
CELL DEATH AND DIFFERENTIATION (2013)
Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis
Sahar A. Saddoughi et al.
EMBO MOLECULAR MEDICINE (2013)
Necroptosis: The Release of Damage-Associated Molecular Patterns and Its Physiological Relevance
Agnieszka Kaczmarek et al.
IMMUNITY (2013)
TAK1 Is Essential for Osteoclast Differentiation and Is an Important Modulator of Cell Death by Apoptosis and Necroptosis
Betty Lamothe et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Plk1 is upregulated in androgen-insensitive prostate cancer cells and its inhibition leads to necroptosis
A. Deeraksa et al.
ONCOGENE (2013)
Shikonin Kills Glioma Cells through Necroptosis Mediated by RIP-1
Chuanjiang Huang et al.
PLOS ONE (2013)
CYLD Deubiquitinates RIP1 in the TNFα-Induced Necrosome to Facilitate Kinase Activation and Programmed Necrosis
David M. Moquin et al.
PLOS ONE (2013)
Resistance to hypoxia-induced necroptosis is conferred by glycolytic pyruvate scavenging of mitochondrial superoxide in colorectal cancer cells
C-Y Huang et al.
CELL DEATH & DISEASE (2013)
Neoalbaconol induces energy depletion and multiple cell death in cancer cells by targeting PDK1-PI3-K/Akt signaling pathway
Q. Deng et al.
CELL DEATH & DISEASE (2013)
Smac mimetic and demethylating agents synergistically trigger cell death in acute myeloid leukemia cells and overcome apoptosis resistance by inducing necroptosis
L. Steinhart et al.
CELL DEATH & DISEASE (2013)
5-Benzylglycinyl-Amiloride Kills Proliferating and Nonproliferating Malignant Glioma Cells through Caspase-Independent Necroptosis Mediated by Apoptosis-Inducing Factor
Nagarekha Pasupuleti et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
Liming Sun et al.
CELL (2012)
TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation
S. Jouan-Lanhouet et al.
CELL DEATH AND DIFFERENTIATION (2012)
Targeting IAP proteins for therapeutic intervention in cancer
Simone Fulda et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
NEMO Inhibits Programmed Necrosis in an NFκB-Independent Manner by Restraining RIP1
Marie Anne O'Donnell et al.
PLOS ONE (2012)
Staurosporine Induces Necroptotic Cell Death under Caspase-Compromised Conditions in U937 Cells
Zsuzsanna A. Dunai et al.
PLOS ONE (2012)
Ubiquitination and degradation of the FADD adaptor protein regulate death receptor-mediated apoptosis and necroptosis
Eun-Woo Lee et al.
NATURE COMMUNICATIONS (2012)
NF-kappaB inhibition improves the sensitivity of human glioblastoma cells to 5-aminolevulinic acid-based photodynamic therapy
Isabelle Coupienne et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Impact of death receptor signaling on the malignancy of pancreatic ductal adenocarcinoma
Christian Roeder et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2011)
The Adaptor Protein FADD Protects Epidermal Keratinocytes from Necroptosis In Vivo and Prevents Skin Inflammation
Marion C. Bonnet et al.
IMMUNITY (2011)
Requirement of FADD, NEMO, and BAX/BAK for Aberrant Mitochondrial Function in Tumor Necrosis Factor Alpha-Induced Necrosis
Krishna M. Irrinki et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation
Patrick-Simon Welz et al.
NATURE (2011)
Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis
Claudia Guenther et al.
NATURE (2011)
Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2
J. Chen et al.
ONCOGENE (2011)
Preclinical evaluation of azathioprine plus buthionine sulfoximine in the treatment of human hepatocarcinoma and colon carcinoma
Borja Hernandez-Breijo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Phase II Study of Obatoclax Mesylate (GX15-070), a Small-Molecule BCL-2 Family Antagonist, for Patients With Myelofibrosis
Sameer A. Parikh et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2010)
Necroptosis as an alternative form of programmed cell death
Dana E. Christofferson et al.
CURRENT OPINION IN CELL BIOLOGY (2010)
Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance
Laura Bonapace et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Molecular mechanisms of necroptosis: an ordered cellular explosion
Peter Vandenabeele et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
An inactivating CYLD mutation promotes skin tumor progression by conferring enhanced proliferative, survival and angiogenic properties to epidermal cancer cells
J. P. Alameda et al.
ONCOGENE (2010)
Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation
YoungSik Cho et al.
CELL (2009)
Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α
Sudan He et al.
CELL (2009)
RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis
Duan-Wu Zhang et al.
SCIENCE (2009)
Targeting the oncogene and kinome chaperone CDC37
Phillip J. Gray et al.
NATURE REVIEWS CANCER (2008)
Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma
James R. Cerhan et al.
BLOOD (2007)
Cell death in health and disease
Richard A. Lockshin et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2007)
Caspase inhibitors: viral, cellular and chemical
B. A. Callus et al.
CELL DEATH AND DIFFERENTIATION (2007)
Cell death by necrosis: towards a molecular definition
Pierre Golstein et al.
TRENDS IN BIOCHEMICAL SCIENCES (2007)
The murine TRAIL receptor signals caspase-independent cell death through cerarnide
Lutz Thon et al.
EXPERIMENTAL CELL RESEARCH (2006)
TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma
A. Trauzold et al.
ONCOGENE (2006)
Tumor metastasis: mechanistic insights and clinical challenges
Patricia S. Steeg
NATURE MEDICINE (2006)
Ceramide mediates caspase-independent programmed cell death
L Thon et al.
FASEB JOURNAL (2005)
A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL-positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity
M Okada et al.
BLOOD (2004)
Dissemination and growth of cancer cells in metastatic sites
AF Chambers et al.
NATURE REVIEWS CANCER (2002)
Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule
N Holler et al.
NATURE IMMUNOLOGY (2000)
分享论文
